Wellbeing and Survival Improvement With Event Reduction by Ablation for Atrial Fibrillation in the Very Elderly (WISER-AF)
Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The WISER-AF trial is a multicenter, double-blind, sham-controlled, randomized controlled trial. It aims to evaluate the efficacy and safety of catheter ablation compared to a sham procedure in improving the quality of life (SF-36 score) in very elderly patients (aged ≥80 years) with symptomatic atrial fibrillation over a 6-month follow-up period.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 80
Healthy Volunteers: f
View:
• Age ≥ 80 years.
• Documented paroxysmal or persistent atrial fibrillation by ECG or Holter within 6 months prior to enrollment.
• Symptomatic AF (including palpitations, chest tightness, fatigue, dizziness, blackouts, dyspnea).
• Voluntary participation and signed informed consent.
Locations
Other Locations
China
Beijing Anzhen Hospital, Capital Medical University, Beijing, China
RECRUITING
Beijing
Contact Information
Primary
Liu He, PhD
theliu@139.com
+86 13810720787
Time Frame
Start Date: 2026-01-30
Estimated Completion Date: 2028-12-30
Participants
Target number of participants: 182
Treatments
Experimental: Catheter Ablation Group
Sham_comparator: Sham Control Group
Related Therapeutic Areas
Sponsors
Leads: Beijing Anzhen Hospital